Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. Recently, the company's subsidiary Shandong Shengdi Pharmaceutical Co., Ltd. received approval from the State Drug Administration to issue a “Drug Clinical Trial Approval Notice” for HRS-1780 tablets and will conduct clinical trials in the near future.

Zhitongcaijing · 3d ago
Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. Recently, the company's subsidiary Shandong Shengdi Pharmaceutical Co., Ltd. received approval from the State Drug Administration to issue a “Drug Clinical Trial Approval Notice” for HRS-1780 tablets and will conduct clinical trials in the near future.